×

Gilead's big Q2 beat

4:12 PM ET Wed, 23 July 2014

Gilead Sciences is reporting Q2 EPS of $2.36 ex-items on revenue of $6.53 billion, with CNBC's Meg Tirrell. Sales of Sovaldi during the second quarter came in at $3.48 billion.